Hanfei Qi

7PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2026
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study.

Valerie Lee, Apoorvaa S Sachidanand, Christina Rodriguez

|Nov 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.

Marina Baretti, Allison M Kirk, Brian H Ladle

|May 23, 2025
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma.

Parul Agarwal, Matthew Guo, Kabeer Munjal

|Oct 25, 2024
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma.

Daniel H Shu, Won Jin Ho, Luciane T Kagohara

|Feb 07, 2024
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.

Junke Wang, Jessica Gai, Tengyi Zhang

|Jan 22, 2024
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers.

Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra

Pageof 2

Frequent Collaborators

5 joint publications

Elizabeth M Jaffee

4 joint publications

Hao Wang

3 joint publications

Daniel Laheru

3 joint publications

Mark Yarchoan